There are multiple other biomarkers as per Table 1 that can aid in the diagnosis of prostate cancer and have been shown to outperform PSA as a diagnostic tool, however their use in clinical practice is variable due to their limitations. The gene discussed is KLK3; the disease is Familial prostate cancer.